InsidersTradesSigma
Browse the detailed record of transactions filed by Mann William Roland, Chief Executive Officer. Director active across 1 companies, notably NeuBase Therapeutics, Inc.. Cumulatively, 1 reports have been published. Total volume traded: €11k. The latest transaction was filed on 30 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
William Roland Mann is the Chief Operating Officer of NeuBase Therapeutics, Inc. He is responsible for overseeing the company's daily operations and ensuring process efficiency. His role is essential for supporting growth and innovation within the organization.